Claudio Marcocci

Active 1981–2025

139
Papers
24,328
Citations
84
h-index
137
i10-index

Citations

Citations per year for Claudio Marcocci1911: 1 citations1948: 2 citations1981: 1 citations1982: 1 citations1983: 3 citations1984: 3 citations1985: 1 citations1986: 4 citations1987: 5 citations1988: 4 citations1989: 9 citations1990: 3 citations1991: 11 citations1992: 9 citations1993: 14 citations1994: 21 citations1995: 13 citations1996: 23 citations1997: 26 citations1998: 34 citations1999: 32 citations2000: 72 citations2001: 45 citations2002: 53 citations2003: 46 citations2004: 61 citations2005: 45 citations2006: 56 citations2007: 55 citations2008: 91 citations2009: 86 citations2010: 79 citations2011: 77 citations2012: 130 citations2013: 98 citations2014: 104 citations2015: 80 citations2016: 106 citations2017: 80 citations2018: 137 citations2019: 464 citations2020: 806 citations2021: 715 citations2022: 630 citations2023: 497 citations2024: 765 citations2025: 414 citations2026: 8 citations1912–1947: no citations, so these years are not shown1949–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,050 citing papers, 19.2% of this breakdownItaly: 699 citing papers, 12.8% of this breakdownChina: 450 citing papers, 8.2% of this breakdownUnited Kingdom: 356 citing papers, 6.5% of this breakdownGermany: 288 citing papers, 5.2% of this breakdownFrance: 210 citing papers, 3.8% of this breakdownNetherlands: 173 citing papers, 3.2% of this breakdownCanada: 160 citing papers, 2.9% of this breakdownAustralia: 127 citing papers, 2.3% of this breakdownDenmark: 126 citing papers, 2.3% of this breakdownSpain: 124 citing papers, 2.3% of this breakdownBelgium: 116 citing papers, 2.1% of this breakdown
0%19.2%Other 29.2%

Fields

  • Medicine90.8%
  • Biochemistry, Genetics and Molecular Biology4.5%
  • Nursing1.6%
  • Immunology and Microbiology1.4%
  • Neuroscience0.5%
  • Computer Science0.3%
  • Other0.9%

Topics

  • Ophthalmology and Eye Disorders8.4%
  • Parathyroid Disorders and Treatments8.2%
  • Vitamin D Research Studies7.4%
  • Thyroid Disorders and Treatments6.7%
  • Thyroid and Parathyroid Surgery5.3%
  • Thyroid Cancer Diagnosis and Treatment3.4%
  • Other60.6%

Coauthors

All papers

Open in search
  1. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions

    Authors: , , , , , , , , , , - Endocrine Reviews 2018 cited by 1,113

  2. Teprotumumab for the Treatment of Active Thyroid Eye Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 700

  3. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop

    Authors: , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2020 cited by 511

  4. Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Endocrine Reviews 2024 cited by 301

  5. Vitamin D in the older population: a consensus statement

    Authors: , , , , , , , - Endocrine 2022 cited by 189

  6. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

    Authors: , , , , , , , , , - European Thyroid Journal 2016 cited by 954

  7. Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?

    Authors: , , , , , , , , , - Reviews in Endocrine and Metabolic Disorders 2021 cited by 162

  8. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2021 cited by 158

  9. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Pilz, Heide Siggelkow, Neil Gittoes, Claudio Marcocci, Peter Kamenický, _ _, Zillikens Carola, Frost Morten, Rolighed Lars, Sitges-Serra Antonio, Corbetta Sabrina, Decallonne Brigitte, Gherlan Iuliana, Gianotti Laura, Grigorie Daniel, Hindié Elif, Kiely Mairead, Lindner Kirsten, Makras Polyzois, Obermayer-Pietsch Barbara, R Perez-Lopez Fastino, Pretorius Mikkel, Saponaro Federica, Trummer Christian, Vamvakidis Kyriakos, Vashakmadze Natia, P Yavropoulou Maria - European Journal of Endocrinology 2021 cited by 201

  10. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2020 cited by 97

  11. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2014 cited by 1,257

  12. Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2012 cited by 363

  13. Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial

    Authors: , , , , , , , , , - The Lancet Diabetes & Endocrinology 2021 cited by 81

  14. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults

    Authors: , , , , , , - European Journal of Endocrinology 2015 cited by 454

  15. Consensus statement from 2nd International Conference on Controversies in Vitamin D

    Authors: , , , , , , , , , , , , , - Reviews in Endocrine and Metabolic Disorders 2020 cited by 256

  16. Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Reviews in Endocrine and Metabolic Disorders 2023 cited by 57

  17. Selenium and the Course of Mild Graves' Orbitopathy

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 608

  18. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A. Jane Dickinson, N. Fichter, László Hegedüs, Onur Konuk, Gerassimos Krassas, Carol Lane, John H. Lazarus, Dan S Morris, Maarten P. Mourits, Marco Nardi, C Neoh, Jacques Orgiazzi, Simon H. S. Pearce, Georg von Arx, Miloš Žarković - The Lancet Diabetes & Endocrinology 2018 cited by 216

  19. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Luisa Brandi, John P. Bilezikian - Osteoporosis International 2016 cited by 538

  20. Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis

    Authors: , , - Frontiers of hormone research 2018 cited by 203

  21. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

    Authors: , , , , , , , _ _, _ _, , , , , , , , , , , , , , , , , , , , , , Brigitte Delemer, Rachel Desailloud, Timo Deutschbein, Tina Dušek, Britt Edén Engström, Marco Faustini‐Fustini, Schillo Franck, C. Garcia, Yona Greenman, Susana Mallea Gil, Giovanna Mantovani, Mark Gurnell, Anthony P. Heaney, David Henley, Claire Higham, E. W. Hoving, Charlotte Höybye, Atsuhiro Ichihara, Marie‐Lise Jaffrain‐Rea, Gudmundur Johannsson, Jens Otto Lunde Jørgensen, Christel Jublanc, Jan Komor, Márta Korbonits, Ivana Kralievic, Delphine Larrieu‐Ciron, Hélène Lasolle, Edward R. Laws, Marco Losa, Dominique Maiter, Claudio Marcocci, Olinda Marques, Tânia Longo Mazzuco, Alexander Micko, Nathalie Bourcigaux, Sebastian Neggers, John Newell‐Price, Belén Perez-Berida, León Darío Ortiz, Óskar Ragnarsson, Marta Ragonese, Martín Reincke, Jean‐Louis Sadoul, Akira Shimatsu, Luis V. Syro, Luc Taillandier, Miklós Tóth, Takeshi Usui, Zauzsanna Valkusz, Greisa Vila, Ben Whitelaw, Maria Chiara Zatelli - European Journal of Endocrinology 2018 cited by 282

  22. Controversies in Vitamin D: A Statement From the Third International Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , - JBMR Plus 2020 cited by 179

  23. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Endocrinology 2008 cited by 797

  24. PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2021 cited by 69